{
  "query": "ARGX",
  "resolved": {
    "ticker": "ARGX",
    "cik": "0001697862",
    "title": "ARGENX SE"
  },
  "signals": [
    {
      "type": "trial_to_filing",
      "headline": "ARGENX SE (ARGX) — trial protocol updated 1 days ago",
      "entity": "argenx",
      "ticker": "ARGX",
      "cik": "0001697862",
      "tickerConfidence": 0.9,
      "upstream": {
        "event": "Clinical trial status (n/a)",
        "detail": "ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis",
        "nctId": "NCT07294170",
        "date": "2028-03-07"
      },
      "observed": {
        "event": "protocol updated 1 days ago",
        "nctId": "NCT07294170"
      },
      "predicted": {
        "event": "SEC 8-K / press release (material trial update)",
        "leadTime": "days–weeks",
        "baseRate": null,
        "note": "Reg FD requires prompt disclosure of material clinical results."
      },
      "leadTime": "days–weeks to disclosure",
      "confidence": 0.35,
      "links": {
        "trial": "https://clinicaltrials.gov/study/NCT07294170",
        "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001697862&type=8-K"
      }
    }
  ],
  "recentFilings": {
    "name": "ARGENX SE",
    "sicDescription": "Biological Products, (No Diagnostic Substances)",
    "filings": []
  },
  "disclaimer": "Research/informational. NOT investment advice.",
  "generatedAt": "2026-09-19T09:01:05.471Z"
}